4.6 Article

Earlier anti-TNF therapy reduces the risk of malnutrition associated with alterations in body composition in patients with Crohn's disease

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Earlier Anti-TNF Initiation Leads to Long-term Lower Health Care Utilization in Crohn's Disease but Not in Ulcerative Colitis

Laura E. Targownik et al.

Summary: Early administration of anti-TNF therapy is associated with reduced healthcare resource utilization in CD, but not in UC.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Nutrition & Dietetics

Correlation Among Body Composition Parameters and Long-Term Outcomes in Crohn's Disease After Anti-TNF Therapy

Katsuyoshi Ando et al.

Summary: This study aimed to investigate the correlation between body composition and long-term outcomes in patients with Crohn's disease after anti-TNF therapy. The results showed that low skeletal muscle mass and the ratio of visceral to subcutaneous fat were associated with poor long-term clinical outcomes.

FRONTIERS IN NUTRITION (2022)

Article Nutrition & Dietetics

Bioelectrical impedance vector analysis (BIVA) in university athletes

Priscila Custodio Martins et al.

Summary: The study found no significant differences in BIVA between team sports athletes and individual sports athletes, with most athletes demonstrating good hydration status and higher body cell mass compared to a non-athlete reference population.

JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION (2021)

Review Nutrition & Dietetics

Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview

Amritpal Dhaliwal et al.

Summary: Sarcopenia, commonly seen in patients with inflammatory bowel disease, has a significant impact on the management of IBD, affecting quality of life, prognosis, and treatment. Research is ongoing to develop interventions to counteract sarcopenia in various chronic inflammatory diseases.

NUTRIENTS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Computed tomography-based multiple body composition parameters predict outcomes in Crohn's disease

Ziling Zhou et al.

Summary: This study found that skeletal muscle and adipose tissue principal component were associated with complicated Crohn's disease behavior and adverse outcome, respectively. Indexes derived from body and lumbar spinal heights have similar efficacies in body composition analysis.

INSIGHTS INTO IMAGING (2021)

Article Nutrition & Dietetics

Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease

Anna Maria Rychter et al.

Summary: The study found that reduced physical activity, smoking, and coffee and alcohol consumption are risk factors for osteoporosis in patients with inflammatory bowel disease. Patients with Crohn's disease who were diagnosed with osteopenia and osteoporosis had significantly lower physical activity levels compared to those with normal bone mineral density. Women with inflammatory bowel disease who had normal bone mineral density exercised more frequently than those with osteopenia and osteoporosis. However, no significant differences were observed in bone mineral density with regards to coffee use, alcohol consumption, or smoking.

NUTRIENTS (2021)

Review Nutrition & Dietetics

Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease

Lewis Steell et al.

Summary: Musculoskeletal deficits are commonly reported in patients with inflammatory bowel disease (IBD), particularly Crohn's disease. The adverse effects on bone and muscle are multifactorial, including inflammation, nutritional deficits, and therapies, leading to increased risk of osteoporosis and sarcopenia. Ib children with IBD, these factors may impact optimal bone and muscle accrual.

NUTRIENTS (2021)

Review Nutrition & Dietetics

Nutritional Aspects in Inflammatory Bowel Diseases

Paola Balestrieri et al.

NUTRIENTS (2020)

Review Gastroenterology & Hepatology

Sarcopenia and Inflammatory Bowel Disease: A Systematic Review

Eanna Ryan et al.

INFLAMMATORY BOWEL DISEASES (2019)

Article Gastroenterology & Hepatology

Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life

Robert Venning Bryant et al.

INFLAMMATORY BOWEL DISEASES (2019)

Article Gastroenterology & Hepatology

Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel Damage

Hinaben Panchal et al.

DIGESTIVE DISEASES AND SCIENCES (2019)

Article Gastroenterology & Hepatology

Visceral Fat Is Associated With Mucosal Healing of Infliximab Treatment in Crohn's Disease

Weisong Shen et al.

DISEASES OF THE COLON & RECTUM (2018)

Article Endocrinology & Metabolism

Increases in IGF-1 After Anti-TNF-alpha Therapy Are Associated With Bone and Muscle Accrual in Pediatric Crohn Disease

Mark D. DeBoer et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Nutrition & Dietetics

Prevalence of Sarcopenia and Its Impact on Postoperative Outcome in Patients With Crohn's Disease Undergoing Bowel Resection

Tenghui Zhang et al.

JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2017)

Article Gastroenterology & Hepatology

Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease

Maria Jose Casanova et al.

JOURNAL OF CROHNS & COLITIS (2017)

Article Gastroenterology & Hepatology

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide

F. Scaldaferri et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2017)

Article Gastroenterology & Hepatology

Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study

M. Eberhardson et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Nutrition & Dietetics

ESPEN guideline: Clinical nutrition in inflammatory bowel disease

Alastair Forbes et al.

CLINICAL NUTRITION (2017)

Review Gastroenterology & Hepatology

Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management

N. S. Ding et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Article Gastroenterology & Hepatology

Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease

K. Subramaniam et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

Article Gastroenterology & Hepatology

Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease

R. V. Bryant et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

Article Gastroenterology & Hepatology

Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?

Veerle Nuij et al.

JOURNAL OF CROHNS & COLITIS (2015)

Article Geriatrics & Gerontology

The Bioimpedance Phase Angle Predicts Low Muscle Strength, Impaired Quality of Life, and Increased Mortality in Old Patients With Cancer

Kristina Norman et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2015)

Review Gastroenterology & Hepatology

Systematic review: body composition in adults with inflammatory bowel disease

R. V. Bryant et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)

Review Gastroenterology & Hepatology

Adipose tissue and inflammatory bowel disease pathogenesis

Christopher Fink et al.

INFLAMMATORY BOWEL DISEASES (2012)

Article Medicine, General & Internal

Maintenance therapy with certolizumab pegol for Crohn's disease

Stefan Schreiber et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Gastroenterology & Hepatology

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial

Jean-Frederic Colombel et al.

GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Nutrition in Crohn disease

KL Krok et al.

CURRENT OPINION IN GASTROENTEROLOGY (2003)

Review Gastroenterology & Hepatology

Nutrition and adult inflammatory bowel disease

J Goh et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)